Q-Cells AG, its subsidiary Calyxo GmbH and U.S.-based Solar Fields LLC have agreed to merge their activities in the production of cadmium-telluride photovoltaic (PV) modules.
The companies note that they have been working closely together since Solar Fields exclusively licensed its deposition technology to Calyxo GmbH. The new agreement is intended to accelerate the development and commercialization of the technology and to make optimal use of its economic potential.
Under the terms of the partnership, Calyxo GmbH will own Solar Fields IP. Solar Fields' assets have been transferred into a US-subsidiary of Calyxo GmbH – the newly formed Calyxo USA Inc., which will focus on research and development activities. In return, Solar Fields has received 7% of the shares in Calyxo GmbH and a one-time payment of $5 million.